ClearBridge Advisors »

Protagonist Therapeutics shares owned by ClearBridge Advisors

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by ClearBridge Advisors from 13F filings

Historical chart of ClearBridge Advisors investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by ClearBridge Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by ClearBridge Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $43M 490k 87.34

More positions owned by ClearBridge Advisors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Netflix (NFLX)
JPMorgan Chase & Co. (JPM)
Taiwan Semiconductor Manufacturing Sponsored Ads (TSM)
Vertex Pharmaceuticals Incorporated (VRTX)
Williams Companies (WMB)
ASML Holding NV N Y Registry Shs (ASML)
Raytheon Technologies Corp (RTX)

View all positions for ClearBridge Advisors

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
Rtw Investments
State Street Corporation
UBS Group
BVF
Johnson & Johnson
Wellington Management Company
Invesco
Geode Capital Management
Woodline Partners
Driehaus Capital Management
Henderson Group
ADAR1 Capital Management

View all funds holding Protagonist Therapeutics